Our results revealed that amyloid depositions were affected by ApoE4 carrier status, which is compatible with previous findings (Reiman et al., 2009), supporting the concept that ApoE4 plays an early role in the pathogenesis of AD. This evidence concerns the gene APOE and Alzheimer disease.